AI models can modify the genetic sequences of known bioweapons like ricin just enough to evade current screening protocols at DNA synthesis companies. This creates functional but 'obfuscated' threats, demonstrating a critical vulnerability in our biodefense supply chain.

Top AI labs and biotech firms are urging the US government to mandate screening for nucleic acid synthesis orders. This pragmatic approach targets a concrete threat—AI-assisted bioweapon creation—rather than abstract superintelligence risks.

The danger of AI creating harmful proteins is not in the digital design but in its physical creation. A protein sequence on a computer is harmless. The critical control point is the gene synthesis process. Therefore, biosecurity efforts should focus on providing advanced screening tools to synthesis providers.

Current concerns focus on AI agents using existing bioinformatics tools. The more advanced threat is agentic AI that can code and create novel, personalized biological tools on demand, moving beyond a static toolset to a dynamic threat generation capability.

Current biosecurity screens for threats by matching DNA sequences to known pathogens. However, AI can design novel proteins that perform a harmful function without any sequence similarity to existing threats. This necessitates new security tools that can predict a protein's function, a concept termed "defensive acceleration."

The belief that nature represents the ceiling of pathogen danger is false. Just as humans engineer materials stronger than any found in nature, AI can be used to design viruses that are far more transmissible or lethal than their natural counterparts.

The underlying AI architecture for creating novel biological sequences is also highly effective at identifying dangerous ones. This dual-use nature means the team building design capabilities is best suited to build defense tools, as the models are fundamentally the same.

Valthos CEO Kathleen, a biodefense expert, warns that AI's primary threat in biology is asymmetry. It drastically reduces the cost and expertise required to engineer a pathogen. The primary concern is no longer just sophisticated state-sponsored programs but small groups of graduate students with lab access, massively expanding the threat landscape.

AI models capable of designing biological sequences are advancing rapidly. The same models can be used for defense (e.g., detecting pathogens), but this defensive side is significantly behind, creating a dangerous imbalance that needs to be addressed.